Clinical Trial Update: Role of the Interaction Between Advanced Glycation End Products and Their Receptor RAGE in the Development and the Progression of the Uremic Vasculopathy of Hemodialyzed Patients [NA]

View source ↗

Summary

A completed clinical study examining how the interaction between advanced glycation end products (AGEs) and the receptor RAGE contributes to the development and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: CHU de Reims | Conditions: Hemodialyzed Patients | NA | Status: COMPLETED